Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $159,150 - $193,200
-15,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $178,800 - $208,800
15,000 New
15,000 $196,000
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $76,200 - $98,325
-7,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $67,800 - $88,950
7,500 New
7,500 $84,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $936M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.